Compositions and methods for cancer treatment
US10377731B2 · kind B2 · utility
3Cited by
18References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2019 |
| Grant date | Aug 13, 2019 |
| Priority date | — |
| Expiry date | Jan 14, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the composition and methods of use of Stat3 pathway inhibitors or cancer stem cell inhibitors in combination treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.